Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptor, Parathyroid Hormone, Type 1 | 9 | 2024 | 307 | 0.950 |
Why?
|
Parathyroid Hormone | 15 | 2024 | 1801 | 0.730 |
Why?
|
Peptides | 12 | 2024 | 4392 | 0.470 |
Why?
|
Epitopes, T-Lymphocyte | 5 | 2024 | 880 | 0.390 |
Why?
|
Parathyroid Hormone-Related Protein | 2 | 2023 | 331 | 0.320 |
Why?
|
Hypoparathyroidism | 2 | 2021 | 120 | 0.300 |
Why?
|
Drug Inverse Agonism | 1 | 2024 | 11 | 0.240 |
Why?
|
Immunodominant Epitopes | 2 | 2021 | 267 | 0.240 |
Why?
|
Receptors, Parathyroid Hormone | 4 | 2006 | 332 | 0.210 |
Why?
|
Histocompatibility Antigens Class I | 4 | 2021 | 1366 | 0.210 |
Why?
|
Vacuolar Proton-Translocating ATPases | 2 | 2014 | 195 | 0.210 |
Why?
|
Flagellin | 2 | 2012 | 125 | 0.200 |
Why?
|
Hypocalcemia | 1 | 2023 | 191 | 0.200 |
Why?
|
T-Lymphocytes, Cytotoxic | 5 | 2012 | 1820 | 0.200 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2021 | 4438 | 0.200 |
Why?
|
Hydrogen Sulfide | 2 | 2012 | 137 | 0.200 |
Why?
|
Arabidopsis Proteins | 2 | 2012 | 262 | 0.190 |
Why?
|
Glucagon-Like Peptide 1 | 2 | 2015 | 334 | 0.180 |
Why?
|
Epitope Mapping | 1 | 2020 | 311 | 0.170 |
Why?
|
Arabidopsis | 2 | 2012 | 459 | 0.170 |
Why?
|
Peptide Fragments | 9 | 2008 | 5095 | 0.160 |
Why?
|
Dwarfism | 1 | 2019 | 145 | 0.160 |
Why?
|
Osteochondrodysplasias | 1 | 2019 | 183 | 0.160 |
Why?
|
Cyclic AMP | 9 | 2016 | 1470 | 0.160 |
Why?
|
Epitopes | 3 | 2020 | 2569 | 0.140 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 2 | 2016 | 491 | 0.130 |
Why?
|
Cytomegalovirus | 1 | 2020 | 730 | 0.130 |
Why?
|
Anesthetics, Inhalation | 1 | 2020 | 571 | 0.130 |
Why?
|
Protein Kinases | 2 | 2012 | 1638 | 0.130 |
Why?
|
Oxazepines | 1 | 2015 | 18 | 0.130 |
Why?
|
Ligands | 8 | 2019 | 3293 | 0.120 |
Why?
|
tau Proteins | 2 | 2023 | 1860 | 0.120 |
Why?
|
Barbiturates | 1 | 2015 | 114 | 0.120 |
Why?
|
Receptors, G-Protein-Coupled | 3 | 2023 | 1221 | 0.120 |
Why?
|
Basal Metabolism | 1 | 2015 | 168 | 0.120 |
Why?
|
Fluorescent Dyes | 2 | 2012 | 1915 | 0.120 |
Why?
|
Alzheimer Disease | 3 | 2023 | 7988 | 0.110 |
Why?
|
Meristem | 1 | 2012 | 17 | 0.110 |
Why?
|
Plant Shoots | 1 | 2012 | 25 | 0.110 |
Why?
|
Plant Immunity | 1 | 2012 | 17 | 0.110 |
Why?
|
Immobilization | 1 | 2014 | 236 | 0.110 |
Why?
|
Immunoconjugates | 1 | 2020 | 897 | 0.110 |
Why?
|
Amino Acid Sequence | 10 | 2013 | 13814 | 0.110 |
Why?
|
Anesthesia | 1 | 2023 | 1548 | 0.100 |
Why?
|
HEK293 Cells | 5 | 2021 | 4200 | 0.100 |
Why?
|
Femoral Vein | 1 | 2012 | 159 | 0.100 |
Why?
|
Antibodies | 1 | 2020 | 2459 | 0.100 |
Why?
|
Sulfides | 1 | 2012 | 166 | 0.100 |
Why?
|
Endosomes | 1 | 2014 | 520 | 0.100 |
Why?
|
Receptors, Vasopressin | 1 | 2011 | 112 | 0.100 |
Why?
|
Chromatography, High Pressure Liquid | 4 | 2009 | 1574 | 0.100 |
Why?
|
Polyethylene Glycols | 1 | 2016 | 1181 | 0.090 |
Why?
|
Amino Acids | 4 | 2023 | 1727 | 0.090 |
Why?
|
Delirium | 1 | 2022 | 1608 | 0.090 |
Why?
|
Amino Acid Substitution | 5 | 2015 | 1792 | 0.090 |
Why?
|
Homozygote | 1 | 2015 | 1777 | 0.090 |
Why?
|
HIV | 3 | 2007 | 1600 | 0.090 |
Why?
|
COS Cells | 5 | 2015 | 1160 | 0.090 |
Why?
|
Endotoxins | 1 | 2012 | 525 | 0.090 |
Why?
|
Fibrin | 1 | 2012 | 506 | 0.090 |
Why?
|
Microscopy, Confocal | 2 | 2013 | 1969 | 0.090 |
Why?
|
GTPase-Activating Proteins | 1 | 2013 | 497 | 0.090 |
Why?
|
HIV Infections | 6 | 2021 | 16678 | 0.090 |
Why?
|
Molecular Sequence Data | 8 | 2013 | 18112 | 0.090 |
Why?
|
Small Molecule Libraries | 1 | 2015 | 721 | 0.080 |
Why?
|
Receptors, Glucagon | 1 | 2008 | 92 | 0.080 |
Why?
|
Mice | 13 | 2024 | 81045 | 0.080 |
Why?
|
Synaptic Transmission | 1 | 2014 | 1179 | 0.070 |
Why?
|
Animals | 22 | 2024 | 168561 | 0.070 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2012 | 895 | 0.070 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2012 | 721 | 0.070 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 503 | 0.070 |
Why?
|
Oligopeptides | 1 | 2012 | 1176 | 0.070 |
Why?
|
Mutation, Missense | 1 | 2015 | 2556 | 0.070 |
Why?
|
Microtubules | 1 | 2011 | 1090 | 0.070 |
Why?
|
LLC-PK1 Cells | 4 | 2011 | 132 | 0.070 |
Why?
|
Molecular Imaging | 1 | 2012 | 831 | 0.060 |
Why?
|
Cross Reactions | 2 | 2020 | 841 | 0.060 |
Why?
|
Weight Gain | 1 | 2015 | 2282 | 0.060 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 2699 | 0.060 |
Why?
|
Signal Transduction | 7 | 2023 | 23387 | 0.060 |
Why?
|
Nucleocapsid | 1 | 2024 | 59 | 0.060 |
Why?
|
Circular Dichroism | 3 | 2013 | 354 | 0.060 |
Why?
|
Protein Structure, Secondary | 4 | 2013 | 1245 | 0.060 |
Why?
|
Indoles | 1 | 2012 | 1834 | 0.060 |
Why?
|
HIV-1 | 3 | 2012 | 6934 | 0.060 |
Why?
|
Energy Metabolism | 1 | 2015 | 2896 | 0.060 |
Why?
|
Alleles | 2 | 2021 | 6931 | 0.060 |
Why?
|
Herpesvirus 8, Human | 1 | 2005 | 258 | 0.060 |
Why?
|
Type C Phospholipases | 3 | 2015 | 292 | 0.060 |
Why?
|
HIV Antigens | 1 | 2004 | 347 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2024 | 4379 | 0.060 |
Why?
|
Viral Proteins | 2 | 2007 | 1899 | 0.060 |
Why?
|
Venous Thrombosis | 1 | 2012 | 1237 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15530 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 1 | 2012 | 1788 | 0.050 |
Why?
|
Sarcoma, Kaposi | 1 | 2005 | 370 | 0.050 |
Why?
|
Bone and Bones | 1 | 2013 | 2575 | 0.050 |
Why?
|
Phosphorylation | 3 | 2023 | 8436 | 0.050 |
Why?
|
Gene Products, vpr | 1 | 2001 | 36 | 0.050 |
Why?
|
Muscle, Skeletal | 2 | 2015 | 4933 | 0.050 |
Why?
|
Mice, Inbred C57BL | 6 | 2016 | 21821 | 0.050 |
Why?
|
Arginine | 2 | 2002 | 944 | 0.050 |
Why?
|
Norleucine | 1 | 2021 | 6 | 0.050 |
Why?
|
Gene Products, rev | 1 | 2001 | 31 | 0.050 |
Why?
|
Protein Denaturation | 1 | 2021 | 237 | 0.050 |
Why?
|
Kidney | 2 | 2016 | 7167 | 0.050 |
Why?
|
Antigens, Viral | 1 | 2005 | 1034 | 0.050 |
Why?
|
Proline | 1 | 2023 | 458 | 0.050 |
Why?
|
Gene Products, tat | 1 | 2001 | 120 | 0.050 |
Why?
|
Glucose | 2 | 2012 | 4391 | 0.050 |
Why?
|
Brain Injuries | 1 | 2012 | 2024 | 0.050 |
Why?
|
Obesity | 2 | 2015 | 12705 | 0.040 |
Why?
|
Protein Stability | 1 | 2021 | 556 | 0.040 |
Why?
|
Humans | 32 | 2024 | 742088 | 0.040 |
Why?
|
Rats | 5 | 2021 | 24265 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2014 | 2552 | 0.040 |
Why?
|
Methionine | 1 | 2021 | 590 | 0.040 |
Why?
|
Oxidation-Reduction | 2 | 2021 | 2187 | 0.040 |
Why?
|
Surface Properties | 1 | 2021 | 1182 | 0.040 |
Why?
|
Biochemistry | 1 | 1999 | 113 | 0.040 |
Why?
|
Brain Ischemia | 1 | 2012 | 3258 | 0.040 |
Why?
|
Phosphotyrosine | 1 | 1999 | 457 | 0.040 |
Why?
|
Swine | 5 | 2011 | 5934 | 0.040 |
Why?
|
Protein Binding | 5 | 2014 | 9387 | 0.040 |
Why?
|
Copper | 1 | 2000 | 366 | 0.040 |
Why?
|
Glutamic Acid | 4 | 2006 | 1167 | 0.040 |
Why?
|
Cell Line, Tumor | 3 | 2021 | 16665 | 0.040 |
Why?
|
Matrix Metalloproteinases | 1 | 2020 | 391 | 0.040 |
Why?
|
Binding, Competitive | 3 | 2004 | 1159 | 0.040 |
Why?
|
Cryoelectron Microscopy | 1 | 2020 | 573 | 0.040 |
Why?
|
Models, Chemical | 2 | 2012 | 626 | 0.040 |
Why?
|
Protein Conformation | 2 | 2020 | 4013 | 0.040 |
Why?
|
Rhodamines | 1 | 2016 | 183 | 0.030 |
Why?
|
Immunomodulation | 1 | 2020 | 540 | 0.030 |
Why?
|
Models, Molecular | 2 | 2021 | 5454 | 0.030 |
Why?
|
Antibody Formation | 1 | 2020 | 1402 | 0.030 |
Why?
|
Hypoglycemic Agents | 1 | 2008 | 2866 | 0.030 |
Why?
|
HLA Antigens | 1 | 2021 | 1382 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2021 | 1372 | 0.030 |
Why?
|
Oxygen | 2 | 2012 | 4169 | 0.030 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 2015 | 114 | 0.030 |
Why?
|
Calcitriol | 1 | 2016 | 298 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2020 | 2723 | 0.030 |
Why?
|
Inositol Phosphates | 2 | 2004 | 180 | 0.030 |
Why?
|
Conotoxins | 1 | 2014 | 20 | 0.030 |
Why?
|
Arrestins | 1 | 2014 | 74 | 0.030 |
Why?
|
Crotalid Venoms | 1 | 2014 | 28 | 0.030 |
Why?
|
Bungarotoxins | 1 | 2014 | 46 | 0.030 |
Why?
|
Mice, Obese | 1 | 2015 | 424 | 0.030 |
Why?
|
Calcium | 2 | 2021 | 5753 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2019 | 9735 | 0.030 |
Why?
|
Fluorescence | 1 | 2016 | 751 | 0.030 |
Why?
|
Male | 13 | 2022 | 349538 | 0.030 |
Why?
|
Brain | 1 | 2020 | 26343 | 0.030 |
Why?
|
Blood Glucose | 1 | 2008 | 6249 | 0.030 |
Why?
|
Lymphocyte Activation | 2 | 2020 | 5519 | 0.030 |
Why?
|
Insulin | 1 | 2008 | 6575 | 0.030 |
Why?
|
Protein Structure, Tertiary | 3 | 2006 | 3847 | 0.030 |
Why?
|
Myography | 1 | 2014 | 109 | 0.030 |
Why?
|
Neurons | 1 | 2012 | 9325 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2015 | 500 | 0.030 |
Why?
|
Inflammation | 1 | 2012 | 10578 | 0.030 |
Why?
|
ADP-Ribosylation Factors | 1 | 2013 | 133 | 0.030 |
Why?
|
Liver | 1 | 2008 | 7470 | 0.030 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2014 | 401 | 0.030 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2012 | 87 | 0.030 |
Why?
|
Cholera Toxin | 1 | 2014 | 553 | 0.030 |
Why?
|
Hyperinsulinism | 1 | 2015 | 415 | 0.030 |
Why?
|
Feedback, Physiological | 1 | 2014 | 479 | 0.030 |
Why?
|
Memantine | 1 | 2012 | 100 | 0.030 |
Why?
|
Gene Knock-In Techniques | 1 | 2013 | 418 | 0.030 |
Why?
|
Peptides, Cyclic | 1 | 2014 | 401 | 0.020 |
Why?
|
Neuromuscular Junction | 1 | 2014 | 397 | 0.020 |
Why?
|
Half-Life | 1 | 2012 | 658 | 0.020 |
Why?
|
Immunotherapy, Adoptive | 1 | 2020 | 1255 | 0.020 |
Why?
|
Phlebography | 1 | 2012 | 333 | 0.020 |
Why?
|
Cells, Cultured | 3 | 2015 | 19223 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 21596 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2020 | 1970 | 0.020 |
Why?
|
Tryptophan | 1 | 2013 | 478 | 0.020 |
Why?
|
Ferric Compounds | 1 | 2012 | 374 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2016 | 3701 | 0.020 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2012 | 449 | 0.020 |
Why?
|
Vasopressins | 1 | 2011 | 370 | 0.020 |
Why?
|
Glutathione | 1 | 2012 | 586 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2012 | 1420 | 0.020 |
Why?
|
Chlorides | 1 | 2012 | 667 | 0.020 |
Why?
|
Phosphates | 1 | 2013 | 786 | 0.020 |
Why?
|
Administration, Inhalation | 1 | 2012 | 1104 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2013 | 2049 | 0.020 |
Why?
|
Atrophy | 1 | 2014 | 1576 | 0.020 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2013 | 581 | 0.020 |
Why?
|
Muscle Contraction | 1 | 2014 | 1241 | 0.020 |
Why?
|
GTP-Binding Proteins | 1 | 2013 | 970 | 0.020 |
Why?
|
Time Factors | 4 | 2015 | 40054 | 0.020 |
Why?
|
Infusions, Parenteral | 1 | 2008 | 415 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2012 | 2027 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2020 | 18006 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2012 | 2335 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2013 | 1727 | 0.020 |
Why?
|
Glucose Clamp Technique | 1 | 2008 | 266 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2005 | 10163 | 0.020 |
Why?
|
Female | 8 | 2022 | 379592 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2000 | 3574 | 0.020 |
Why?
|
Structure-Activity Relationship | 2 | 2004 | 3133 | 0.020 |
Why?
|
Fatty Acids | 1 | 2015 | 1806 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2013 | 10943 | 0.020 |
Why?
|
Cattle | 2 | 2003 | 3923 | 0.020 |
Why?
|
Drug Design | 1 | 2012 | 1078 | 0.020 |
Why?
|
Cell Death | 1 | 2012 | 1695 | 0.020 |
Why?
|
Cell Line | 3 | 2006 | 15994 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2015 | 1368 | 0.020 |
Why?
|
Blotting, Western | 1 | 2014 | 5180 | 0.020 |
Why?
|
Reperfusion Injury | 1 | 2012 | 1025 | 0.020 |
Why?
|
Protein Transport | 1 | 2011 | 1988 | 0.020 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2006 | 407 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2008 | 1150 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2007 | 1799 | 0.020 |
Why?
|
Alanine | 1 | 2006 | 572 | 0.010 |
Why?
|
Inhibitory Concentration 50 | 1 | 2004 | 459 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18355 | 0.010 |
Why?
|
Opossums | 1 | 2003 | 106 | 0.010 |
Why?
|
Ischemia | 1 | 2012 | 1911 | 0.010 |
Why?
|
Entropy | 1 | 2004 | 209 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2012 | 6382 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2013 | 6608 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2013 | 3760 | 0.010 |
Why?
|
Radioligand Assay | 1 | 2002 | 379 | 0.010 |
Why?
|
Lactams | 1 | 2003 | 155 | 0.010 |
Why?
|
vpr Gene Products, Human Immunodeficiency Virus | 1 | 2001 | 39 | 0.010 |
Why?
|
Capsid Proteins | 1 | 2005 | 479 | 0.010 |
Why?
|
Homeostasis | 1 | 2013 | 3335 | 0.010 |
Why?
|
Gene Products, vif | 1 | 2001 | 33 | 0.010 |
Why?
|
vif Gene Products, Human Immunodeficiency Virus | 1 | 2001 | 53 | 0.010 |
Why?
|
Human Immunodeficiency Virus Proteins | 1 | 2001 | 65 | 0.010 |
Why?
|
rev Gene Products, Human Immunodeficiency Virus | 1 | 2001 | 28 | 0.010 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 2001 | 159 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2016 | 13029 | 0.010 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 1 | 2001 | 127 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2022 | 15244 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2012 | 21719 | 0.010 |
Why?
|
Histidine | 1 | 2000 | 313 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 2005 | 1606 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2006 | 1670 | 0.010 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 1 | 1999 | 146 | 0.010 |
Why?
|
Catalysis | 1 | 2000 | 760 | 0.010 |
Why?
|
Mutation | 1 | 2023 | 29717 | 0.010 |
Why?
|
Lysine | 1 | 2003 | 1008 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2002 | 1526 | 0.010 |
Why?
|
Societies, Scientific | 1 | 1999 | 220 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 2004 | 2557 | 0.010 |
Why?
|
AIDS Vaccines | 1 | 2004 | 938 | 0.010 |
Why?
|
Glutamine | 1 | 2000 | 574 | 0.010 |
Why?
|
Gene Frequency | 1 | 2004 | 3587 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2013 | 9410 | 0.010 |
Why?
|
Hydrogen Peroxide | 1 | 2000 | 730 | 0.010 |
Why?
|
Tyrosine | 1 | 2000 | 1460 | 0.010 |
Why?
|
Laboratories | 1 | 1999 | 461 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13256 | 0.010 |
Why?
|
Viral Load | 1 | 2004 | 3292 | 0.010 |
Why?
|
Anti-Retroviral Agents | 1 | 2004 | 1712 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2001 | 6313 | 0.010 |
Why?
|
Cell Membrane | 1 | 2002 | 3744 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2000 | 1989 | 0.010 |
Why?
|
Iron | 1 | 2000 | 1773 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 1999 | 2203 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 24913 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2005 | 5851 | 0.010 |
Why?
|
Aged | 1 | 2022 | 162944 | 0.010 |
Why?
|
Data Collection | 1 | 1999 | 3339 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20086 | 0.010 |
Why?
|
Middle Aged | 2 | 2012 | 213127 | 0.000 |
Why?
|
Adult | 2 | 2012 | 213712 | 0.000 |
Why?
|
Young Adult | 1 | 2012 | 56350 | 0.000 |
Why?
|
Longitudinal Studies | 1 | 2001 | 13921 | 0.000 |
Why?
|